# Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment

> **NCT01485900** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 20 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** SAR407899A

## Key facts

- **NCT ID:** NCT01485900
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485900, "Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment". Retrieved via AI Analytics 2026-09-13 from https://api.ai-analytics.org/clinical/NCT01485900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*